Rom S Leidner
14PUBLICATIONS
122CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.Tessa F Flores, Emily S Tonorezos, Shailender Bhatia
|Aug 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.Robert L Ferris, Rom S Leidner, Christine H Chung
|Jan 06, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.Juanita Lopez, Thomas Powles, Fadi Braiteh
|Nov 12, 2024
Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System.Alexa K Dowdell, Ryan C Meng, Ann Vita
|Oct 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Francis P Worden, Evan Pisick, Michael Rothe
|Dec 26, 2023
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.David A Knorr, Lucas Blanchard, Rom S Leidner
Pageof 3
Frequent Collaborators
3 joint publications
Richard B Bell
2 joint publications
Brian Piening
2 joint publications
Robert L Ferris
2 joint publications
Ryan Meng
2 joint publications
Ryan J Sullivan
2 joint publications
George N Pavlakis
2 joint publications
Walter J Urba
2 joint publications
Sumati Gupta
2 joint publications
Kevin Conlon
2 joint publications
Douglas G McNeel
